Biotech company raises £3.7m to fund research into age-related disease
Biotech company SENISCA has raised £3.7m from existing and new investors to fund its research into treatments for age-related disease.
The University of Exeter spinout has developed proprietary technology that harnesses RNA biology to reprogram aged "senescent" cells.
They are cells which behave differently to young, healthy cells in several ways, and are emerging as causal factors for multiple age-related diseases.
The company has now raised £7.1m from investors, alongside £1.1m in Innovate UK grants, awards, and commerci... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
